Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05791877 · ClinicalTrials.gov registry record · NA
Non-Invasive Measurement of Pulmonary Dysfunction in Children With Cerebral Palsy
A NA study of Cerebral Palsy, sponsored by Nemours Children's Clinic.
- Recruiting
- Registry status
- NA
- Development phase
- 250
- Enrollment target
- 1
- Study location
NCT05791877: Recruiting NA study of Cerebral Palsy, sponsored by Nemours Children's Clinic.
NCT05791877 is a NA study of Cerebral Palsy that is actively recruiting participants, run by Nemours Children's Clinic. The registered enrollment target is 250 participants, above the 227-participant average among 91 other Cerebral Palsy trials with a reported enrollment target (10% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05791877, a NA study of Cerebral Palsy, is actively recruiting participants, sponsored by Nemours Children's Clinic.
- RECRUITING
- Registry status
- NA
- Development phase
- 250 participants
- Enrollment target
- 1
- Study location
Study Summary
This proposal addresses pulmonary dysfunction in severe cerebral palsy by using a novel non-invasive respiratory sensor. The two aims of the project are to 1) provide a screening tool to detect respiratory distress and 2) Find a correlation between the degree of pulmonary dysfunction and scoliosis in children with cerebral palsy.
Primary Outcome
The presence of pulmonary dysfunction will be recorded for each subject. Presence will be determined clinically by the physician. Pulmonary dysfunction can take the form of pneumonia, ineffective airway clearance or atelectasis.
Conditions Studied
Interventions
- DEVICE pneuRIP
Study Locations (1)
Delaware
- Nemours Children's Hospital - Wilmington
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 250 participants |
| Start Date | 2023-10-02 |
| Est. Completion | 2026-11 |
| Phase | NA |
What NCT05791877 shows while recruiting
NCT05791877 is an interventional study that assigns participants to a tested intervention. The registered 250 participants enrollment target is mid-sized for trials with a published cap, above the 227-participant average among 91 other Cerebral Palsy trials with a reported enrollment target (10% higher).
The record links to 1 condition, with Cerebral Palsy appearing as the primary indexed condition, and to 1 intervention - of which pneuRIP is the first listed.
NCT05791877 reports a single indexed study location in Delaware.
Frequently Asked Questions
What is clinical trial NCT05791877 about?
NCT05791877 is a clinical study titled "Non-Invasive Measurement of Pulmonary Dysfunction in Children With Cerebral Palsy". This proposal addresses pulmonary dysfunction in severe cerebral palsy by using a novel non-invasive respiratory sensor. The two aims of the project are to 1) provide a screening tool to detect respiratory distress and 2) Find a correlation between the degree of pulmonary dysfunction and scoliosis i...
What is the current status of trial NCT05791877?
This trial is currently recruiting. It is a NA study. The enrollment target is 250 participants. The study started on 2023-10-02. Estimated completion is 2026-11.
What conditions does trial NCT05791877 study?
This clinical trial studies the following conditions: Cerebral Palsy.
What interventions are being tested in trial NCT05791877?
The interventions under investigation include: pneuRIP (DEVICE).
Who is sponsoring clinical trial NCT05791877?
This trial is sponsored by Nemours Children's Clinic, which has 108 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05791877 being conducted?
This trial has 1 study location across Delaware. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cerebral Palsy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05791877's enrollment target sits among peer trials
250 11th of 91 higher than 81 of 91 other Cerebral Palsy trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cerebral Palsy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Motor Training for Infants With Cerebral Palsy
RECRUITING · NA
-
Implementation of Therapy Together
RECRUITING · NA
-
Evaluating Long-term Use of a Pediatric Robotic Exoskeleton (P.REX/Agilik) to Improve Gait in Children With Movement Disorders
RECRUITING · NA
-
Em-power: Maximizing Functional Independence for Children With Severe Cerebral Palsy
RECRUITING · NA
-
Neuromodulation of the Cortex and Spinal Cord
RECRUITING · NA
-
Effectiveness of Robotic Gait Training and Physical Therapy for Children and Youth With Cerebral Palsy
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00483249 · 250 participants · NA
Endovascular Exclusion of Thoracoabdominal and/or Paravisceral Abdominal Aortic Aneurysm
- NCT00777712 · 250 participants
Mechanisms Underlying Impaired Diabetic Wound Healing
- NCT01451502 · 250 participants · NA
Infusion of Cell Populations From Unlicensed Umbilical Cord Blood Units
- NCT01771718 · 250 participants
Pilot Study on In-vivo Non-invasive Skin Imaging Using Multiphoton Microscopy
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI